Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Dyscrasia Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02697344
What this trial is testing

Gossypol Acetic Acid With Lenalidomide and Dexamethasone in Treating Patients With Relapsed Symptomatic Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell Myeloma
Mayo Clinic 10
Early research (Phase 1)Study completedNCT00093600
What this trial is testing

PKC412, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
Novartis Pharmaceuticals 69
Testing effectiveness (Phase 2)Study completedNCT01133275
What this trial is testing

Lenalidomide and Prednisone in Low and Int-1 Myelodysplastic Syndrome (MDS) Non 5q MDS

Who this might be right for
Myelodysplastic SyndromeMDS
H. Lee Moffitt Cancer Center and Research Institute 28
Early research (Phase 1)Study completedNCT00476177
What this trial is testing

Donor Dendritic Cells And Donor Lymphocytes in Patients With Relapsed Hematologic Malignancies After Allogeneic Transplant

Who this might be right for
Hematologic Malignancy
Dana-Farber Cancer Institute 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT05354557
What this trial is testing

Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT)

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 16
Not applicableEnded earlyNCT01685411
What this trial is testing

Busulfan and Cyclophosphamide Followed By ALLO BMT

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome
Masonic Cancer Center, University of Minnesota 5
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Not applicableStudy completedNCT04356144
What this trial is testing

Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical Infections

Who this might be right for
Disseminated Intravascular CoagulationCritical IllnessSars-CoV2+3 more
Medical University of Vienna 58
Testing effectiveness (Phase 2)Looking for participantsNCT05863234
What this trial is testing

Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia

Who this might be right for
Aggressive NK Cell Leukemia
Hiroshima University Hospital 7
Testing effectiveness (Phase 2)Ended earlyNCT02226172
What this trial is testing

Single-Agent Glasdegib In Patients With Myelofibrosis Previously Treated With Ruxolitinib

Who this might be right for
Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis
Pfizer 21
Not applicableStudy completedNCT03438981
What this trial is testing

Optimization of PK/PD Target Attainment for Ceftriaxone in Critically Ill Patients With Community-acquired Pneumonia.

Who this might be right for
PharmacokineticsCritical Illness
Universitaire Ziekenhuizen KU Leuven 30
Post-approval studies (Phase 4)Ended earlyNCT00706667
What this trial is testing

Intravenous Ferric Carboxymaltose (Ferinject®) With or Without Erythropoietin in Patients Undergoing Orthopaedic Surgery

Who this might be right for
Iron Deficiency Anemia
University of Zurich 75
Large-scale testing (Phase 3)Not Yet RecruitingNCT06136507
What this trial is testing

Study of Efficacy and Safety of FRSW107 in Pediatric Patients With Severe Hemophilia A

Who this might be right for
Severe Hemophilia A
Hangzhou Gensciences Biopharmaceutical Co., Ltd. 76
Testing effectiveness (Phase 2)Looking for participantsNCT07400341
What this trial is testing

Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AA

Who this might be right for
MDS (Myelodysplastic Syndrome)Aplastic Anemia (AA)
The First Affiliated Hospital of Soochow University 66
Not applicableStudy completedNCT01503541
What this trial is testing

S9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With Standard Chemotherapy With or Without Gemtuzumab Ozogamicin

Who this might be right for
Leukemia
SWOG Cancer Research Network 365
Not applicableStudy completedNCT03099031
What this trial is testing

Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE)

Who this might be right for
Venous Thromboembolism
LEO Pharma 420
Testing effectiveness (Phase 2)Ended earlyNCT03457142
What this trial is testing

Abatacept, Ixazomib Citrate, and Dexamethasone in Treating Patients With Multiple Myeloma Resistant to Chemotherapy

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Roswell Park Cancer Institute 15
Not applicableLooking for participantsNCT06513273
What this trial is testing

Observational Study on the Outcome of AML Patients Treated With New Drugs in Real-life (BoxTrial)

Who this might be right for
Acute Myeloid LeukemiaAML, AdultAcute Myeloid Leukemia, Adult
Gruppo Italiano Malattie EMatologiche dell'Adulto 397
Testing effectiveness (Phase 2)Looking for participantsNCT07228273
What this trial is testing

Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
OHSU Knight Cancer Institute 102
Early research (Phase 1)Study completedNCT00357305
What this trial is testing

Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic Leukemia+31 more
National Cancer Institute (NCI) 25
Next Page